CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleMarket cap is $1.51B, above the global median of $1.15B
- PositionP/E ratio is 15.33×, lower than 95% of its Specialty Chemicals peers (median 42.43×)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.61%Above 5Y avg (2.59%)
Annual Rate
CNY 1.50Paid annual
Payout Ratio
52.2%Sustainable
Payback Period
16.8 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.14BCNY1.51B · vs all stocks (USD)
Trailing P/E
15.33xvs Specialty Chemicals peers
Revenue (TTM)
3.54BCNY525.15M · vs all stocks (USD)
Profit Margin
19.27%vs Specialty Chemicals peers
Beta
-0.0350xvs all stocks
52-Week Change
-45.34%vs all stocks
Market Capitalization
10.14BCNY1.51B · vs all stocks (USD)
Enterprise Value
9.29BCNY1.38B · vs all stocks (USD)
Trailing P/E
15.33xvs Specialty Chemicals peers
Forward P/E
7.77xvs Specialty Chemicals peers
PEG Ratio
-0.3329xvs Specialty Chemicals peers
Price to Sales (TTM)
2.94xvs Specialty Chemicals peers
Price to Book (MRQ)
2.59xvs Specialty Chemicals peers
Enterprise to Revenue
2.63xvs Specialty Chemicals peers
Enterprise to EBITDA
11.05xvs Specialty Chemicals peers
Gross Margin
33.85%vs Specialty Chemicals peers
Profit Margin
19.27%vs Specialty Chemicals peers
Operating Margin
18.77%vs Specialty Chemicals peers
Return on Assets (TTM)
9.23%vs Specialty Chemicals peers
Return on Equity (TTM)
18.12%vs Specialty Chemicals peers
Revenue (TTM)
3.54BCNY525.15M · vs all stocks (USD)
Revenue per Share (TTM)
9.18CNYUpdated Aug 20, 2026Quarterly Revenue Growth
3.20%vs Specialty Chemicals peers
Gross Profit (TTM)
1.21BCNY179.68M · vs all stocks (USD)
EBITDA (TTM)
940.83MCNY139.73M · vs all stocks (USD)
Net Income (TTM)
681.38MCNY101.20M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-28.20%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
783.50MCNY116.37M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
326.66MCNY48.52M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.50CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
5.61%vs all stocks
5-Year Average Dividend Yield
2.59%vs all stocks
Payout Ratio
52.17%vs Specialty Chemicals peers
Minority Interest (Equity)
27.82MCNYFY2025 · Dec 31, 2025Revenue
3.51BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.29BCNYFY2025 · Dec 31, 2025Gross Profit
1.21BCNYFY2025 · Dec 31, 2025Operating Income
830.03MCNY123.28M · vs all stocks (USD)
Pre-tax Income
851.53MCNYFY2025 · Dec 31, 2025Income Tax Expense
109.90MCNYFY2025 · Dec 31, 2025Net Income
741.63MCNYFY2025 · Dec 31, 2025EBIT
863.32MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
940.83MCNYFY2025 · Dec 31, 2025Research & Development
160.60MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
85.71MCNYFY2025 · Dec 31, 2025Other Operating Expenses
21.39MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
11.80MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.92CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.92CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
382.92MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
382.92MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
741.63MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.24MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
659.82MCNYFY2025 · Dec 31, 2025Free Cash Flow
342.03MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
834.21MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
741.63MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.13MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-138.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
37.34MCNYFY2025 · Dec 31, 2025Capital Expenditures
-317.80MCNYFY2025 · Dec 31, 2025Purchase of Investments
-117.08MCNYFY2025 · Dec 31, 2025Sale of Investments
5.78MCNYFY2025 · Dec 31, 2025Other Investing Activity
10.63MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-418.47MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
607.88MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-286.58MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-358.92MCNYFY2025 · Dec 31, 2025Other Financing Charges
69.47MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
31.85MCNYFY2025 · Dec 31, 2025Shares Outstanding
384.72MSharesUpdated Aug 20, 2026Float Shares
180.59MSharesUpdated Aug 20, 2026% Held by Insiders
50.76%vs all stocks
% Held by Institutions
20.82%vs all stocks
Total Cash (MRQ)
1.80BCNY267.71M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.78CNYUpdated Aug 20, 2026Total Debt (MRQ)
821.97MCNY122.08M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2062xvs Specialty Chemicals peers
Current Ratio (MRQ)
2.46xvs Specialty Chemicals peers
Book Value per Share (MRQ)
10.49CNYUpdated Aug 20, 2026Total Assets
5.10BCNY756.90M · vs all stocks (USD)
Total Current Assets
3.01BCNYFY2025 · Dec 31, 2025Total Liabilities
1.25BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.09BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
151.63MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.10BCNYFY2025 · Dec 31, 2025Cash
834.15MCNYFY2025 · Dec 31, 2025Cash Equivalents
7.05MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
841.19MCNYFY2025 · Dec 31, 2025Other Short-term Investments
906.21MCNYFY2025 · Dec 31, 2025Accounts Receivable
485.35MCNYFY2025 · Dec 31, 2025Inventory
535.78MCNYFY2025 · Dec 31, 2025Accounts Payable
371.67MCNYFY2025 · Dec 31, 2025Short-term Debt
562.58MCNYFY2025 · Dec 31, 2025Other Current Liabilities
490.61KCNYFY2025 · Dec 31, 2025Long-term Debt
138.57MCNYFY2025 · Dec 31, 2025Common Stock (Book)
295.94MCNYFY2025 · Dec 31, 2025Retained Earnings
1.80BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.85BCNY571.66M · vs all stocks (USD)
Treasury Stock
228.20MCNYFY2025 · Dec 31, 202552-Week Low
26.34CNYUpdated Aug 20, 202652-Week High
51.00CNYUpdated Aug 20, 202652-Week Change
-45.34%vs all stocks
Beta
-0.0350xvs all stocks
50-Day MA
29.29CNYUpdated Aug 20, 2026200-Day MA
38.28CNYUpdated Aug 20, 2026Avg 10-Day Volume
3.97MSharesUpdated Aug 20, 2026Avg 30-Day Volume
4.17MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
1.77CNYUpdated Aug 20, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 15.33×, lower than 95% of its Specialty Chemicals peers (median 42.43×)Notable
P/E ratio: 15.33Industry median: 42.43Industry P5: 15.33Peers compared: 144
Financial Health
Altman Z-Score 7.07: safe zoneNotable
Altman Z-Score: 7.07
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is $1.51B, above the global median of $1.15BNotable
Market cap (USD): 1,505,294,555.349Global Median: 1,146,734,693.424
Revenue is $525.15M, above the global median of $520.53MNotable
Revenue (USD): 525,148,089.651Global Median: 520,528,949.311
Levered free cash flow is $48.52M, above the global median of $16.24MNotable
Levered free cash flow (USD): 48,516,004.206Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Yantai Zhenghai Magnetic Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Jiangsu Yunyi Electric Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
CEAT Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Leggett & Platt, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Nancal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong TCL Smart Home Appliances Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Chongqing Zaisheng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Stanley Agricultural Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dalian Huarui Heavy Industry Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Huadian Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Xiamen Amoytop Biotech Co., Ltd.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedOperating Income Growing With Multi-Year Revenue GrowthPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity
Motomotion China Corp.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedOperating Income Growing With Multi-Year Revenue GrowthPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity
Want Want China Holdings Limited
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.